Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT00185393
Eligibility Criteria:
Inclusion Criteria:
* Non Hodgkin Lymphoma stage III or IV at timepoint of diagnosis
* Patients who have achieved a remission after first line chemotherapy
* No less than 6 weeks and no more than 12 weeks since last dose of chemotherapy
* older than 18 years
* written informed consent
Exclusion Criteria:
* Any other anticancer treatment for NHL except the preceding first line chemotherapy
* Prior radiation therapy
* Patients who have not recovered from the toxic effects of the first line chemotherapy
* Any other cancer or history of cancer less than 10 years ago
* Patients with known HIV positivity
* patients with pleural effusion or ascites
* female patients who are pregnant or breast feeding (women of childbearing potential must have a negative serum pregnancy test at study entry)
* Adults not employing an effective method of birth control during study treatment and 12 months thereafter
* Patients unable or unwilling to comply with protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00185393
Study Brief:
Protocol Section:
NCT00185393